Establishment of a 6-signature risk model associated with cellular senescence for predicting the prognosis of breast cancer

被引:2
|
作者
Zhang, Xiu-Xia [1 ,3 ]
Yu, Xin [1 ]
Zhu, Li [2 ]
Luo, Jun-Hua [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Thyroid & Breast Surg, Linping Campus, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Pathol Dept, Linping Campus, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Thyroid & Breast Surg, 369 Yingbin Rd,Nanyuan St,Linping Campus, Hangzhou 311100, Zhejiang, Peoples R China
关键词
biomarkers; breast cancer; prognosis; risk model; senescence; TUMOR-ASSOCIATED MACROPHAGES; IMMUNOSURVEILLANCE; INVASION;
D O I
10.1097/MD.0000000000035923
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study focused on screening novel markers associated with cellular senescence for predicting the prognosis of breast cancer. The RNA-seq expression profile of BRCA and clinical data were obtained from TCGA. The pam algorithm was used to cluster patients based on senescence-related genes. The weighted gene co-expression network analysis was used to identify co-expressed genes, and LASSO-Cox analysis was performed to build a risk prognosis model. The performance of the model was also evaluated. We additionally explored the role of senescence in cancer development and possible regulatory mechanism. The patients were clustered into 2 subtypes. A total of 5259 genes significantly related to senescence were identified by weighted gene co-expression network analysis. LASSO-Cox finally established a 6-signature risk model (ADAMTS8, DCAF12L2, PCDHA10, PGK1, SLC16A2, and TMEM233) that exhibited favorable and stable performance in our training, validation, and whole BRCA datasets. Furthermore, the superiority of our model was also observed after comparing it to other published models. The 6-signature was proved to be an independent risk factor for prognosis. In addition, mechanism prediction implied the activation of glycometabolism processes such as glycolysis and TCA cycle under the condition of senescence. Glycometabolism pathways were further found to negatively correlate with the infiltration level of CD8 T-cells and natural killer cells but positively correlate with M2 macrophage infiltration and expressions of tissue degeneration biomarkers, which suggested the deficit immune surveillance and risk of tumor migration. The constructed 6-gene model based on cellular senescence could be an effective indicator for predicting the prognosis of BRCA.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] A 6-gene signature predicting lung metastasis in breast cancer
    Landemaine, Y.
    Jackson, A.
    Bellahcene, A.
    Sierra, A.
    Castronovo, V
    Teti, A.
    Lidereau, R.
    Driouch, K.
    BULLETIN DU CANCER, 2007, 94 (06) : 542 - 542
  • [42] Identification of a novel cellular senescence-related signature for the prediction of prognosis and immunotherapy response in colon cancer
    Dai, Longfei
    Wang, Xu
    Bai, Tao
    Liu, Jianjun
    Chen, Bo
    Li, Ting
    Yang, Wenqi
    FRONTIERS IN GENETICS, 2022, 13
  • [43] AI - model for predicting breast cancer risk
    Graewert, Stephanie
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2024, 196 (01): : 21 - 22
  • [44] A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer
    Zhang, Juan
    Zhang, Mi
    Tian, Qi
    Yang, Jin
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (07) : 3867 - 3881
  • [45] A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer
    Juan Zhang
    Mi Zhang
    Qi Tian
    Jin Yang
    Clinical and Experimental Medicine, 2023, 23 : 3867 - 3881
  • [46] Eleven inflammation-related genes risk signature model predicts prognosis of patients with breast cancer
    Hu, Huanhuan
    Yuan, Shenglong
    Fu, Yuqi
    Li, Huixin
    Xiao, Shuyue
    Gong, Zhen
    Zhong, Shanliang
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (07)
  • [47] Identification of an optimized glycolytic-related risk signature for predicting the prognosis in breast cancer using integrated bioinformatic analysis
    Jiang, Di
    Zhang, Ling-Yu
    Wang, Dan-Hua
    Liu, Yan-rong
    MEDICINE, 2023, 102 (35) : E34715
  • [48] A risk model based on lncRNA-miRN-AmRNA gene signature for predicting prognosis of patients with bladder cancer
    Zhao, Zhi Yi
    Cao, Yin
    Wang, Hong Liang
    Liu, Ling Yun
    CANCER BIOMARKERS, 2024, 39 (04) : 277 - 287
  • [49] A zinc metabolism-related gene signature for predicting prognosis and characteristics of breast cancer
    Hong, Jinghui
    Li, Mengxin
    Chen, Yichang
    Du, Ye
    Song, Dong
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [50] Construction and Identification of a Novel 5-Gene Signature for Predicting the Prognosis in Breast Cancer
    Guo, Lingling
    Jing, Yu
    FRONTIERS IN MEDICINE, 2021, 8